Searchable abstracts of presentations at key conferences in endocrinology

ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts

Published by BioScientifica

Previous issue | Volume 50 | SFEBES2017 | Next issue

Society for Endocrinology BES 2017

Harrogate, UK
06 Nov 2017 - 08 Nov 2017

SfE BES 2017 will be on the 6-8 November 2016 in Harrogate, UK.

Poster Presentations

Neoplasia, Cancer and Late Effects

Previous section
Diabetes and Cardiovascular

Table of contents

Next section
Neuroendocrinology and Pituitary

ea0050p241 | Neoplasia, Cancer and Late Effects

Population remodeling in the acquisition of endocrine resistance in breast cancer

ea0050p242 | Neoplasia, Cancer and Late Effects

Combination of JQ1, an inhibitor of epigenetic pathways, and everolimus for treatment of pancreatic and bronchial neuroendocrine tumours

ea0050p243 | Neoplasia, Cancer and Late Effects

Analysis of the diagnosis, treatment and genetics of 175 cases of phaeochromocytoma and paraganglioma in two ENETS Centres of Excellence

ea0050p244 | Neoplasia, Cancer and Late Effects

Identifying linkages between EDCs in personal care products and breast cancer through data integration and gene network analysis

ea0050p245 | Neoplasia, Cancer and Late Effects

Assessment of protective factors from the development of radiation induced hypopituitarism: A single centre study

ea0050p246 | Neoplasia, Cancer and Late Effects

The course of the endocrine disease in POEMS syndrome

ea0050p247 | Neoplasia, Cancer and Late Effects

Check point inhibitor monoclonal antibody therapy – Are there effective markers for endocrine immune-related adverse events?

ea0050p248 | Neoplasia, Cancer and Late Effects

In-house method for the detection of miRNA 145 and 21 in plasma samples of breast cancer patients using SYBR green reverse transcription-qPCR

ea0050p249 | Neoplasia, Cancer and Late Effects

Multiple endocrine neoplasia type 1 (MEN1) phenocopy due to a P.Leu380Phe cell division cycle 23 (CDC73) mutation

ea0050p250 | Neoplasia, Cancer and Late Effects

Immunotherapy and development of endocrine dysfunction: An audit of immune checkpoint inhibitors

ea0050p251 | Neoplasia, Cancer and Late Effects

Endocrinopathies are a frequent Consequence of Immune Checkpoint Inhibitor Therapy, with a Low Recovery Rate of both Thyroid and Pituitary Dysfunction

ea0050p252 | Neoplasia, Cancer and Late Effects

Primary pulmonary typical carcinoid as a source of ectopic Adrenocorticotropic hormone (ACTH)-dependant Cushing’s

ea0050p253 | Neoplasia, Cancer and Late Effects

Challenges in diagnosis and management of tumour induced oncogenic osteomalacia

ea0050p254 | Neoplasia, Cancer and Late Effects

Giant insulinoma: an unusual cause of hypoglycaemia

ea0050p256 | Neoplasia, Cancer and Late Effects

Endocrine adverse effects after immune checkpoint inhibitor therapy in patients with metastatic melanoma: Experience from a single tertiary level centre

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Biosci Abstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more